Return to Library
HIDA scan Visual Overview
Topic

HIDA scan

💡 What You Need to Know

  • Purpose of HIDA Scan: A hepatobiliary iminodiacetic acid (HIDA) scan is a nuclear medicine imaging procedure used to diagnose problems of the liver, gallbladder, and bile ducts.
  • How it Works: A small amount of radioactive tracer is injected into a vein, which travels to the liver, is excreted into the bile, and then flows into the gallbladder and bile ducts.
  • Key Diagnoses: Primarily used to detect acute cholecystitis (gallbladder inflammation), chronic cholecystitis, bile duct obstruction, and assess gallbladder ejection fraction.
  • Procedure Duration: The scan typically takes 1 to 4 hours, depending on the findings and whether additional imaging or medication administration (e.g., cholecystokinin) is required.

🤒 Associated Symptoms

  • Right Upper Quadrant Pain: Persistent or severe pain in the upper right abdomen, often worsening after fatty meals, is a primary indication.
  • Nausea and Vomiting: Unexplained episodes of nausea and vomiting, particularly when associated with abdominal pain.
  • Jaundice: Yellowing of the skin or eyes, which may suggest a bile duct obstruction.
  • Fever and Chills: Systemic signs of inflammation or infection, potentially indicating acute cholecystitis.
  • Abnormal Liver Function Tests: Elevated bilirubin or alkaline phosphatase levels that suggest biliary issues.

🛡 Crucial Precautions

  • Pregnancy and Breastfeeding: Inform your physician immediately if you are pregnant, suspect you might be pregnant, or are breastfeeding, as the radioactive tracer can pose risks.
  • Fasting Requirements: Strict adherence to fasting guidelines (typically 4-12 hours, but not more than 24 hours) is essential for accurate results.
  • Medication Review: Disclose all current medications, especially opioids, which can affect the sphincter of Oddi and interfere with scan interpretation.
  • Recent Barium Studies: Inform the medical team if you have had any recent barium contrast studies, as residual barium can obscure imaging.
  • Allergies: Report any known allergies to medications, especially to cholecystokinin (CCK) if it is planned for gallbladder ejection fraction assessment.

🍽 Dietary Directions & Restrictions

  • Pre-Procedure Fasting: You must fast for 4 to 12 hours prior to the scan. This means no food or drink (except sips of water for medication) during this period.
  • Avoid Prolonged Fasting: Do not fast for more than 24 hours, as this can lead to a false-positive result (non-visualization of the gallbladder).
  • No Fatty Meals: Avoid consuming fatty foods for at least 24 hours before your fasting period begins, as this can affect gallbladder contraction and tracer uptake.
  • Hydration Post-Scan: After the scan, drink plenty of fluids to help flush the radioactive tracer from your system.
  • Medication Adjustments: Discuss with your doctor if any of your regular medications, particularly pain relievers, need to be temporarily stopped before the scan.

⚠️ Attendant Guidelines

  • Radiation Exposure: The HIDA scan involves a small amount of radiation exposure, which is generally considered safe but should be discussed with your physician if you have concerns.
  • Allergic Reactions: While rare, allergic reactions to the radioactive tracer or to cholecystokinin (if administered) can occur. Report any unusual symptoms immediately.
  • Discomfort During CCK Infusion: If cholecystokinin is administered, some patients may experience mild abdominal cramping or nausea, which is usually temporary.
  • Post-Procedure Monitoring: You will be monitored for a short period after the scan to ensure there are no immediate adverse reactions.
  • Activity Restrictions: Generally, there are no specific activity restrictions after a HIDA scan, but follow any specific instructions given by your healthcare provider.

🩺 Physician's Perspective

  • Diagnostic Accuracy: The HIDA scan is highly sensitive and specific for acute cholecystitis, especially when combined with clinical presentation and laboratory findings.
  • Differential Diagnosis: It is invaluable in differentiating between acute cholecystitis, chronic cholecystitis, and other causes of right upper quadrant pain.
  • Gallbladder Ejection Fraction: When cholecystokinin is used, the scan provides a quantitative measure of gallbladder function, aiding in the diagnosis of biliary dyskinesia.
  • Biliary Obstruction Assessment: The scan can help identify bile duct obstruction by observing the flow of tracer into the small intestine.
  • Correlation with Clinical Picture: Results must always be interpreted in the context of the patient's symptoms, physical examination, and other imaging studies.

🎓 Academic & Nursing Corner

  • Patient Education: Provide clear instructions regarding fasting, medication adjustments, and what to expect during and after the procedure to alleviate anxiety.
  • Pre-Scan Assessment: Verify NPO status, review medication history (especially opioids), and confirm pregnancy/breastfeeding status.
  • IV Access: Ensure secure intravenous access for tracer injection and potential CCK administration.
  • Monitoring During Scan: Observe the patient for any signs of discomfort or adverse reactions, particularly during CCK infusion.
  • Post-Scan Instructions: Educate the patient on the importance of hydration to facilitate tracer excretion and advise on when to expect results.

🔬 Clinical Reference Index

  • Radiopharmaceutical: Technetium-99m (Tc-99m) labeled iminodiacetic acid (IDA) derivatives, such as mebrofenin or disofenin, are commonly used.
  • Mechanism of Action: IDA compounds are taken up by hepatocytes and excreted into bile, allowing visualization of the hepatobiliary system.
  • Cholecystokinin (CCK) Administration: Synthetic CCK (e.g., sincalide) is administered intravenously to stimulate gallbladder contraction and measure the gallbladder ejection fraction (GBEF).
  • Morphine Augmentation: In cases of non-visualization of the gallbladder within 60 minutes, morphine may be administered to constrict the sphincter of Oddi, promoting tracer entry into the gallbladder if the cystic duct is patent.
  • Interpretation Criteria: Non-visualization of the gallbladder within 60-90 minutes (or after morphine) suggests acute cholecystitis. Delayed visualization (2-4 hours) may indicate chronic cholecystitis.